Phreesia Free Cash Flow 2019-2025 | PHR

Phreesia free cash flow from 2019 to 2025. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
Phreesia Annual Free Cash Flow
2025 8.29
2024 -57.48
2023 -116.33
2022 -105.52
2021 -15.69
2020 -11.49
2019 -11.96
2018 -23.11
Phreesia Quarterly Free Cash Flow
2025-01-31 8.29
2024-10-31 -0.91
2024-07-31 -2.51
2024-04-30 -6.17
2024-01-31 -57.48
2023-10-31 -46.53
2023-07-31 -34.91
2023-04-30 -19.74
2023-01-31 -116.33
2022-10-31 -93.83
2022-07-31 -66.35
2022-04-30 -40.66
2022-01-31 -105.52
2021-10-31 -61.29
2021-07-31 -22.26
2021-04-30 -12.37
2021-01-31 -15.69
2020-10-31 -12.29
2020-07-31 -7.92
2020-04-30 -1.17
2020-01-31 -11.49
2019-10-31 -9.60
2019-07-31 -3.05
2019-04-30 -0.69
2019-01-31
2018-10-31 -5.47
2018-07-31 -3.92
2018-01-31
Sector Industry Market Cap Revenue
Medical MEDICAL INFO SYS $1.483B $0.420B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) US $37.757B 52.15
Tempus AI (TEM) US $8.929B 0.00
Hims & Hers Health (HIMS) US $8.034B 129.14
Inspire Medical Systems (INSP) US $4.699B 91.27
IRhythm Technologies (IRTC) US $3.466B 0.00
Privia Health (PRVA) US $2.778B 208.18
Enovis (ENOV) US $1.976B 12.23
Schrodinger (SDGR) US $1.817B 0.00
Clover Health Investments (CLOV) US $1.696B 0.00
Omnicell (OMCL) US $1.470B 31.70
Azenta (AZTA) US $1.199B 55.81
10x Genomics (TXG) US $0.991B 0.00
Butterfly Network (BFLY) US $0.568B 0.00
Fulgent Genetics (FLGT) US $0.532B 0.00
Talkspace (TALK) US $0.527B 313.00
Veradigm (MDRX) US $0.476B 0.00
Standard BioTools (LAB) US $0.422B 0.00
TruBridge (TBRG) US $0.390B 0.00
Claritev (CTEV) US $0.360B 0.00
Health Catalyst (HCAT) US $0.280B 0.00
Nyxoah SA (NYXH) BE $0.205B 0.00
SOPHiA GENETICS SA (SOPH) CH $0.201B 0.00
Pulmonx (LUNG) US $0.152B 0.00
American Well (AMWL) US $0.097B 0.00
EUDA Health Holdings (EUDA) SG $0.091B 0.00
Retrieve Medical Holdings (RMHI) US $0.085B 0.00
MDxHealth SA (MDXH) BE $0.082B 0.00
CareCloud (CCLD) US $0.075B 3.24
111 (YI) CN $0.071B 0.00
P3 Health Partners (PIII) US $0.064B 0.00
HeartBeam (BEAT) US $0.059B 0.00
Zepp Health (ZEPP) CN $0.041B 0.00
Outset Medical (OM) US $0.040B 0.00
Zhongchao (ZCMD) CN $0.029B 0.00
ImmunoPrecise Antibodies (IPA) CA $0.021B 0.00
Bullfrog AI Holdings (BFRG) US $0.017B 0.00
MSP Recovery (MSPR) US $0.016B 0.00
Streamline Health Solutions (STRM) US $0.013B 0.00
Healthcare Triangle (HCTI) US $0.012B 0.00
Strata Skin Sciences (SSKN) US $0.011B 0.00
Predictive Oncology (POAI) US $0.010B 0.00
Precipio (PRPO) US $0.010B 0.00
Movano (MOVE) US $0.006B 0.00
Mobile-health Network Solutions (MNDR) SG $0.004B 0.00
HeartSciences (HSCS) US $0.004B 0.00
Tivic Health Systems (TIVC) US $0.003B 0.00
Future Health ESG (FHLT) US $0.000B 0.00